echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Watson Bio launches Phase IIIb clinical trial of new crown mRNA vaccine booster

    Watson Bio launches Phase IIIb clinical trial of new crown mRNA vaccine booster

    • Last Update: 2022-01-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Rubik's Cube Info

    Author: Sunshine

    On November 24, the website of the China Clinical Trial Registration Center showed that Watson Bio-registered an evaluation of the new coronavirus mRNA vaccine (ARCoVaX) in 18-59 years old and 60 years old and above who have been vaccinated with the new coronavirus inactivated vaccine.


    ARCoVaX is an mRNA vaccine jointly developed by Abbio, Watson Bio and the Academy of Military Medicine to prevent new coronary pneumonia caused by SARS-CoV-2 infection


    According to the information disclosed by Abbio, the protection rate of ARCoVaX is equivalent to that of the marketed vaccine.


    On May 11, 2020, Watson Biotech and Abbio signed the "Technology Development Cooperation Agreement" to jointly develop the new coronavirus mRNA vaccine research and development and commercial production


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.